PHGE BiomX Inc.
Price Chart
Executive Summary
BiomX Inc. appointed Roy Rousso as Chief Business Officer (and, per the consulting agreement, COO/CBO) effective July 1, 2026, via a consulting agreement with $11,900/month base compensation at a 70% engagement level, plus eligibility for an annual performance bonus of up to $71,400 and a 200,000-share equity grant vesting over three years. This is a routine officer appointment with no material financial data or strategic changes disclosed, and no departures were announced.
Actionable Insight
Routine officer appointment with no stock-moving implications. Monitor for potential transition to full-time employment or changes in engagement level, but no immediate trading catalyst.
Key Facts
- Appointed Roy Rousso as Chief Business Officer effective July 1, 2026
- Consulting agreement: $11,900/month base fee (70% of full-time $17,000/month)
- Annual performance bonus up to 50% of base fee (up to $71,400 per annum at 70% engagement)
- Equity grant of 200,000 shares of common stock, vesting in 3 equal annual installments
- 12-month post-termination non-compete and non-solicitation covenants
- Part-time independent contractor arrangement; parties intend to transition to full-time salaried employment as business develops
Financial Impact
Annual cash compensation of approximately $142,800 in base fee plus up to $71,400 bonus potential at current engagement level; 200,000 share equity award with three-year vesting
Risk Factors
- Part-time engagement may limit bandwidth relative to a full-time COO/CBO
- Equity grant adds modest shareholder dilution (~200K shares vs $16M market cap)
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-061772 |
| Document: ea0292479-8k_biomx.htm | 0001213900-26-061772 |
| Document: 0001213900-26-061772-index-headers.html | 0001213900-26-061772 |
| Document: 0001213900-26-061772-index.html | 0001213900-26-061772 |
| Document: 0001213900-26-061772.txt | 0001213900-26-061772 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
12d ago
|
8-K
| $1.56 $0.8680 | ▼ −44.36% | ▼ −44.31% | $0.6815 (−56.31%) |
|
Apr 30, 2026
5w ago
|
10-K/A
| $0.7900 $0.6270 | ▼ −20.63% | ▼ −22.98% | $0.6815 (−13.73%) |
|
Apr 16, 2026
7w ago
|
8-K
| $1.84 $1.11 | ▼ −39.67% | ▼ −40.23% | $0.6815 (−62.96%) |
|
Apr 13, 2026
8w ago
|
8-K
| $2.63 $1.46 | ▼ −44.49% | ▼ −47.78% | $0.6815 (−74.09%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $2.63 $1.46 | ▼ −44.49% | ▼ −47.78% | $0.6815 (−74.09%) |
|
Apr 10, 2026
8w ago
|
8-K
| $2.89 $1.84 | ▼ −36.33% | ▼ −40.84% | $0.6815 (−76.42%) |
|
Apr 10, 2026
8w ago
|
Press Release
| $2.89 $1.84 | ▼ −36.33% | ▼ −40.84% | $0.6815 (−76.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access